561 related articles for article (PubMed ID: 29378824)
21. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.
da Silva IDS; Apolinário TA; de Andrade Agostinho L; Paiva CLA
J Mol Neurosci; 2022 May; 72(5):1116-1124. PubMed ID: 35275350
[TBL] [Abstract][Full Text] [Related]
22. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
[TBL] [Abstract][Full Text] [Related]
23. Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects.
Ooi J; Langley SR; Xu X; Utami KH; Sim B; Huang Y; Harmston NP; Tay YL; Ziaei A; Zeng R; Low D; Aminkeng F; Sobota RM; Ginhoux F; Petretto E; Pouladi MA
Cell Rep; 2019 Feb; 26(9):2494-2508.e7. PubMed ID: 30811996
[TBL] [Abstract][Full Text] [Related]
24. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
[TBL] [Abstract][Full Text] [Related]
25. Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death.
Conforti P; Camnasio S; Mutti C; Valenza M; Thompson M; Fossale E; Zeitlin S; MacDonald ME; Zuccato C; Cattaneo E
Neurobiol Dis; 2013 Feb; 50():160-70. PubMed ID: 23089356
[TBL] [Abstract][Full Text] [Related]
26. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
Savitt D; Jankovic J
J Neurol Sci; 2019 Jul; 402():57-61. PubMed ID: 31103960
[TBL] [Abstract][Full Text] [Related]
27. Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington's Disease?
Oosterloo M; Van Belzen MJ; Bijlsma EK; Roos RA
J Huntingtons Dis; 2015; 4(2):141-8. PubMed ID: 26397895
[TBL] [Abstract][Full Text] [Related]
28. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
[TBL] [Abstract][Full Text] [Related]
29. A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.
Bañez-Coronel M; Porta S; Kagerbauer B; Mateu-Huertas E; Pantano L; Ferrer I; Guzmán M; Estivill X; Martí E
PLoS Genet; 2012; 8(2):e1002481. PubMed ID: 22383888
[TBL] [Abstract][Full Text] [Related]
30. Dominant-Negative Effects of Adult-Onset Huntingtin Mutations Alter the Division of Human Embryonic Stem Cells-Derived Neural Cells.
Lopes C; Aubert S; Bourgois-Rocha F; Barnat M; Rego AC; Déglon N; Perrier AL; Humbert S
PLoS One; 2016; 11(2):e0148680. PubMed ID: 26863614
[TBL] [Abstract][Full Text] [Related]
31. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
[TBL] [Abstract][Full Text] [Related]
32. CAG repeat instability in embryonic stem cells and derivative spermatogenic cells of transgenic Huntington's disease monkey.
Khampang S; Parnpai R; Mahikul W; Easley CA; Cho IK; Chan AWS
J Assist Reprod Genet; 2021 May; 38(5):1215-1229. PubMed ID: 33611676
[TBL] [Abstract][Full Text] [Related]
33. Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells.
Wiatr K; Szlachcic WJ; Trzeciak M; Figlerowicz M; Figiel M
Mol Neurobiol; 2018 Apr; 55(4):3351-3371. PubMed ID: 28497201
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic alterations mediate iPSC-induced normalization of DNA repair gene expression and TNR stability in Huntington's disease cells.
Mollica PA; Zamponi M; Reid JA; Sharma DK; White AE; Ogle RC; Bruno RD; Sachs PC
J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29898922
[TBL] [Abstract][Full Text] [Related]
35. REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.
Apolinário TA; Paiva CL; Agostinho LA
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387881
[TBL] [Abstract][Full Text] [Related]
36. Gene Therapy for Huntington's Disease Using Targeted Endonucleases.
Dabrowska M; Olejniczak M
Methods Mol Biol; 2020; 2056():269-284. PubMed ID: 31586354
[TBL] [Abstract][Full Text] [Related]
37. Huntington's disease affects mitochondrial network dynamics predisposing to pathogenic mitochondrial DNA mutations.
Neueder A; Kojer K; Gu Z; Wang Y; Hering T; Tabrizi S; Taanman JW; Orth M
Brain; 2024 Jun; 147(6):2009-2022. PubMed ID: 38195181
[TBL] [Abstract][Full Text] [Related]
38. Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.
Tousley A; Kegel-Gleason KB
J Huntingtons Dis; 2016 Jun; 5(2):99-131. PubMed ID: 27372054
[TBL] [Abstract][Full Text] [Related]
39. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
40. A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.
Chheda P; Chanekar M; Salunkhe Y; Dama T; Pais A; Pande S; Bendre R; Shah N
Mol Diagn Ther; 2018 Jun; 22(3):353-359. PubMed ID: 29619771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
